NISA INVESTMENT ADVISORS, LLC - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 265 filers reported holding ROYALTY PHARMA PLC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 1.0%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$165,554
-51.0%
6,100
-44.5%
0.00%
-50.0%
Q2 2023$338,140
+218054.8%
11,000
+155.8%
0.00%
+100.0%
Q1 2023$155
-97.5%
4,300
-97.2%
0.00%
-97.9%
Q4 2022$6,079
-98.5%
153,819
+1414.1%
0.05%
+1100.0%
Q3 2022$415,000
+12.2%
10,159
+9.9%
0.00%
+33.3%
Q4 2021$370,000
-7.3%
9,244
-16.2%
0.00%
+50.0%
Q3 2021$399,00011,0270.00%
Other shareholders
ROYALTY PHARMA PLC shareholders Q4 2021
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
View complete list of ROYALTY PHARMA PLC shareholders